Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALGRX 4975 in Total Knee Arthroplasty
NCT00132392Phase 2Completed
- Sponsor
- AlgoRx Pharmaceuticals
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of capsaicin in postoperative pain (2 arms), sponsored by AlgoRx Pharmaceuticals. Primary endpoint: Daily average of the numerical rating scale (NRS) for pain with active range of motion of the operated knee at Day 2. Started Jul 2005; status: completed.
02
Drugs
capsaicin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00132392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132392.